Product Name:

WASP-pY291


Product Number:

ab-pn545

Price:

Regular price
$89.00
Regular price
Sale price
$89.00

Download Product PDF

Target Full Name: Wiskott-Aldrich syndrome protein

Product Type Specific: WASP phosphosite-specific antibody

Antibody Code: PN545

Antibody Target Type: Phosphosite-specific

Antibody Phosphosite: Y291

Protein UniProt: P42768

Protein SigNET: P42768

Antibody Type: Polyclonal

Antibody Host Species: Rabbit

Antibody Immunogen Source: Human WASP sequence peptide Cat. No.: PE-04AFC99

Antibody Immunogen Sequence: KLI(pY)DFI(bA)C

Antibody Immunogen Description: Corresponds to amino acid residues K288 to I294; In the PBD domain

Production Method: Corresponds to amino acid residues K288 to I294; In the PBD domain

Antibody Modification: WASP phosphosite-specific antibody

Antibody Concentration: 1 mg/ml

Storage Buffer: Phosphate buffered saline pH 7.4, 0.05% Thimerasol

Storage Conditions: For long term storage, keep frozen at -40°C or lower. Stock solution can be kept at +4°C for more than 3 months. Avoid repeated freeze-thaw cycles.

Product Use: Western blotting | Antibody microarray

Antibody Dilution Recommended: 2 µg/ml for immunoblotting

Antibody Species Reactivity: Human

Antibody Positive Control: The observed molecular mass of the processed target protein on SDS-PAGE gels is reported to be around 54-62 kDa.

Antibody Specificity: Very high

Antibody Cross Reactivity: No significant cross-reactive proteins in sea star oocytes.

Related Product 1: WASP-pY291 blocking peptide

Scientific Background: WASP is a member of the Wiskott-Aldrich syndrome (WAS) family of proteins. It is a cytoplasmic protein expressed exclusively in hematopoietic cells. WASP transduces signals from surface receptors to the actin cytoskeleton. It associates with the small GTPase, Cdc42, to regulate formation of actin filaments, and the cytoskeletal organizing complex, Arp2/3. It is mutated in Wiskott-Aldrich syndrome,which is a rare, inherited, X-linked, recessive disease characterized by immune dysregulation and microthrombocytopenia.